Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

NCT03736928 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

401

Enrollment

INDUSTRY

Sponsor class

Conditions

Glabellar Frown Lines

Interventions

BIOLOGICAL: AbobotulinumtoxinA dose level 1 or 2
OTHER: placebo
BIOLOGICAL: AbobotulinumtoxinA dose 3
BIOLOGICAL: AbobotulinumtoxinA dose 4

Sponsor

Galderma R&D